Aureobasidium-Derived Soluble Branched (1,3-1,6) beta-Glucan (Sophy beta-glucan) Enhances Natural Killer Activity in Leishmania amazonensis-Infected Mice
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
The β-glucans derived from yeast cell walls have been reported for having many immunomodulatory activities in vivo and in vitro. In this study, Aureobasidium-derived soluble branched (1,3-1,6) β-glucan (Sophy β-glucan) was checked for natural killer (NK) activity and for the production of IFN-γ and IL-4 in Leishmania amazonensis infection. The main experiment was performed with a group of female C57BL/6 and BALB/c mice, orally supplemented with 5% of Sophy β-glucan and infected with promastogotes of L. amazonensis (1 × 107) into the footpad. Increase in the footpad thickness with time was observed in BALB/c mice in spite of the oral Sophy β-glucan supplement, but it was less in C57BL/6 mice. The difference in overall mean footpad thickness between 'infection only' versus 'infection + glucan' groups was statistically significant (P < 0.001). High NK activity in C57BL/6 than BALB/c mice was observed in 'glucan only' group compared to the control group and also in 'infection + glucan' group compared to 'infection only' group. The difference in the NK activity among these groups was significant (P < 0.05). The IFN-γ level increased at weeks 7 and 8 post-infection in C57BL/6 mice and was significantly high in 'infection + glucan' group compared to the 'infection only' group (P < 0.05). IL-4 levels did not increase up to detectable levels throughout the study. The results led a conclusion that Sophy β-glucan enhances NK activity and cellular immunity in L. amazonensis-infected mice.
Abstract
The β-glucans derived from yeast cell walls have been reported for having many immunomodulatory activities in vivo and in vitro. In this study, Aureobasidium-derived soluble branched (1,3-1,6) β-glucan (Sophy β-glucan) was checked for natural killer (NK) activity and for the production of IFN-γ and IL-4 in Leishmania amazonensis infection. The main experiment was performed with a group of female C57BL/6 and BALB/c mice, orally supplemented with 5% of Sophy β-glucan and infected with promastogotes of L. amazonensis (1 × 107) into the footpad. Increase in the footpad thickness with time was observed in BALB/c mice in spite of the oral Sophy β-glucan supplement, but it was less in C57BL/6 mice. The difference in overall mean footpad thickness between 'infection only' versus 'infection + glucan' groups was statistically significant (P < 0.001). High NK activity in C57BL/6 than BALB/c mice was observed in 'glucan only' group compared to the control group and also in 'infection + glucan' group compared to 'infection only' group. The difference in the NK activity among these groups was significant (P < 0.05). The IFN-γ level increased at weeks 7 and 8 post-infection in C57BL/6 mice and was significantly high in 'infection + glucan' group compared to the 'infection only' group (P < 0.05). IL-4 levels did not increase up to detectable levels throughout the study. The results led a conclusion that Sophy β-glucan enhances NK activity and cellular immunity in L. amazonensis-infected mice.
참고문헌 (22)
- Almeida RP, "Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB", C mice, 1996, pp.54, 178~184
- Grimaldi GJr, "Leishmaniases of the New World: current concepts and implications for future research", Clin Microbiol Rev, 6, pp.230~250 (1993)
- Ji J, "Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis", Infect Immun, 71, pp.4278~4288 (2003)
- Scott P, "Immunoregulation of cutaneous leishmaniases: T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens", J Exp Med, 168, pp.1675~1684 (1988)
- Scharton TM, "Natural killer cells are a source of interferon- gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice", J Exp Med, 178, pp.567~577 (1993)
- Manners DJ, "The structure of a beta-(1- 3)-glucan from yeast cell walls", Biochem J, 135, pp.19~30 (1973)
- Teas J, "The dietary intake of Laminarin, a brown seaweed, and breast cancer prevention", Nutr Cancer, 4, pp.217~222 (1983)
- Wasser SP, "Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective", Crit Rev Immunol, 19, pp.65~96 (1999)
- Shen J, "Potententian of intestinal immunity by micellary mushroom extracts", Biomed Res, 28, pp.71~77 (2007)
- Li B, "Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88- and Syk kinasedependent pathways", Clin Immunol, 124, pp.170~181 (2007)
- Brown GD, "Immune recognition of fungal beta-glucans", Cell Microbiol, 7, pp.471~479 (2005)
- Taylor PR, "The beta-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte", macrophage and neutrophil lineages, 2002, pp.169, 3876~3882
- Brown GD, "Dectin-1 is a major betaglucan receptor on macrophages", J Exp Med, 196, pp.407~412 (2002)
- Viriyakosol S, "Innate immunity to the pathogenic fungus Coccidioides posadasii is dependent on Toll-like receptor 2 and Dectin-1", Infect Immune, 73, pp.1553~1560 (2005)
- Gantner BN, "Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2", J Exp Med, 197, pp.1107~1117 (2003)
- Ikewaki N, "Immunological actions of Sophy-b-glucan (b-1,3-1,6 glucan), currently available commercially as a health food supplement", Microbiol Immunol, 51, pp.861~873 (2007)
- Yun CH, "Immunomodulatory effects of oat beta-glucan administered intragastrically or parenterally on mice infected with Eimeria vermiformis", Microbiol Immunol, 42, pp.457~465 (1998)
- , tumor necrosis factor alpha, and IL-12) production elicited in splenic macrophages by tilorone treatment of mice during acute systemic candidiasis, "Clin Diag Lab Immunol", 2002, 1282~1294
- De Felippe JJr, "Infection prevention in patients with severe multiple trauma with the immunomodulator beta1-3 polyglucose (glucan)", Surg Gynecol Obstet, 177, pp.383~388 (1993)
- Ohmura Y, "Protective effects of a protein-bound polysaccharide, PSK, on Candida albicans infection in mice via tumor necrosis factor-a induction", Int Immunopharmacol, 1, pp.1797~1811 (2001)
- Williams DL, "Immunotherapeutic modification of Escherichia coli-induced experimental peritonitis and bacteremia by glucan", Surgery, 93, pp.448~454 (1983)
- Djeu JY, "Augmentation of mouse natural killer activity and induction of interferon by tumor cells in vivo", J Exp Med, 151, pp.781~789 (1980)